ID   AT1A2_HUMAN             Reviewed;        1020 AA.
AC   P50993; D3DVE4; Q07059; Q5JW74; Q86UZ5; Q9UQ25;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha-2;
DE            Short=Na(+)/K(+) ATPase alpha-2 subunit;
DE            EC=3.6.3.9;
DE   AltName: Full=Sodium pump subunit alpha-2;
DE   Flags: Precursor;
GN   Name=ATP1A2; Synonyms=KIAA0778;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2477373;
RA   Shull M.M., Pugh D.G., Lingrel J.B.;
RT   "Characterization of the human Na,K-ATPase alpha 2 gene and
RT   identification of intragenic restriction fragment length
RT   polymorphisms.";
RL   J. Biol. Chem. 264:17532-17543(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 211-249.
RC   TISSUE=Leukocyte;
RX   PubMed=3035563; DOI=10.1073/pnas.84.12.4039;
RA   Shull M.M., Lingrel J.B.;
RT   "Multiple genes encode the human Na+,K+-ATPase catalytic subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4039-4043(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 251-442.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=3036582; DOI=10.1016/0014-5793(87)80677-4;
RA   Sverdlov E.D., Monastyrskaya G.S., Broude N.E., Ushkaryov Y.A.,
RA   Allikmets R.L., Melkov A.M., Smirnov Y.V., Malyshev I.V.,
RA   Dulubova I.E., Petrukhin K.E., Gryshin A.V., Kiyatkin N.I.,
RA   Kostina M.B., Sverdlov V.E., Modyanov N.N., Ovchinnikov Y.A.;
RT   "The family of human Na+,K+-ATPase genes. No less than five genes
RT   and/or pseudogenes related to the alpha-subunit.";
RL   FEBS Lett. 217:275-278(1987).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-4.
RX   PubMed=2537767; DOI=10.1016/0014-5793(89)80588-5;
RA   Sverdlov E.D., Bessarab D.A., Malyshev I.V., Petrukhin K.E.,
RA   Smirnov Y.V., Ushkaryov Y.A., Monastyrskaya G.S., Broude N.E.,
RA   Modyanov N.N.;
RT   "Family of human Na+,K+-ATPase genes. Structure of the putative
RT   regulatory region of the alpha+-gene.";
RL   FEBS Lett. 244:481-483(1989).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7711835; DOI=10.3109/09687689409160435;
RA   Hundal H.S., Maxwell D.L., Ahmed A., Darakhshan F., Mitsumoto Y.,
RA   Klip A.;
RT   "Subcellular distribution and immunocytochemical localization of Na,K-
RT   ATPase subunit isoforms in human skeletal muscle.";
RL   Mol. Membr. Biol. 11:255-262(1994).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-570 AND SER-587, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   VARIANTS FHM2 GLN-689 AND THR-731.
RX   PubMed=12953268; DOI=10.1002/ana.10674;
RA   Vanmolkot K.R.J., Kors E.E., Hottenga J.-J., Terwindt G.M., Haan J.,
RA   Hoefnagels W.A.J., Black D.F., Sandkuijl L.A., Frants R.R.,
RA   Ferrari M.D., van den Maagdenberg A.M.J.M.;
RT   "Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated
RT   with familial hemiplegic migraine and benign familial infantile
RT   convulsions.";
RL   Ann. Neurol. 54:360-366(2003).
RN   [12]
RP   VARIANTS FHM2 PRO-764 AND ARG-887, AND CHARACTERIZATION OF VARIANTS
RP   FMH2 PRO-764 AND ARG-887.
RX   PubMed=12539047; DOI=10.1038/ng1081;
RA   De Fusco M., Marconi R., Silvestri L., Atorino L., Rampoldi L.,
RA   Morgante L., Ballabio A., Aridon P., Casari G.;
RT   "Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit
RT   associated with familial hemiplegic migraine type 2.";
RL   Nat. Genet. 33:192-196(2003).
RN   [13]
RP   VARIANT AHC1 ASN-378.
RX   PubMed=15174025; DOI=10.1002/ana.20134;
RA   Swoboda K.J., Kanavakis E., Xaidara A., Johnson J.E., Leppert M.F.,
RA   Schlesinger-Massart M.B., Ptacek L.J., Silver K., Youroukos S.;
RT   "Alternating hemiplegia of childhood or familial hemiplegic migraine?
RT   A novel ATP1A2 mutation.";
RL   Ann. Neurol. 55:884-887(2004).
RN   [14]
RP   VARIANT FHM2 ARG-715.
RX   PubMed=21352219; DOI=10.1111/j.1526-4610.2010.01793.x;
RA   De Sanctis S., Grieco G.S., Breda L., Casali C., Nozzi M.,
RA   Del Torto M., Chiarelli F., Verrotti A.;
RT   "Prolonged sporadic hemiplegic migraine associated with a novel de
RT   novo missense ATP1A2 gene mutation.";
RL   Headache 51:447-450(2011).
RN   [15]
RP   VARIANT FHM2 TRP-1007.
RX   PubMed=23838748; DOI=10.1177/0333102413495116;
RA   Pisano T., Spiller S., Mei D., Guerrini R., Cianchetti C.,
RA   Friedrich T., Pruna D.;
RT   "Functional characterization of a novel C-terminal ATP1A2 mutation
RT   causing hemiplegic migraine and epilepsy.";
RL   Cephalalgia 33:1302-1310(2013).
RN   [16]
RP   VARIANT FHM2 SER-874.
RX   PubMed=23918834; DOI=10.1177/0333102413498941;
RA   Costa C., Prontera P., Sarchielli P., Tonelli A., Bassi M.T.,
RA   Cupini L.M., Caproni S., Siliquini S., Donti E., Calabresi P.;
RT   "A novel ATP1A2 gene mutation in familial hemiplegic migraine and
RT   epilepsy.";
RL   Cephalalgia 34:68-72(2014).
RN   [17]
RP   VARIANTS ALA-366 AND TRP-593.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme,
CC       which catalyzes the hydrolysis of ATP coupled with the exchange of
CC       sodium and potassium ions across the plasma membrane. This action
CC       creates the electrochemical gradient of sodium and potassium,
CC       providing the energy for active transport of various nutrients.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + Na(+)(In) + K(+)(Out) = ADP +
CC       phosphate + Na(+)(Out) + K(+)(In).
CC   -!- SUBUNIT: Composed of three subunits: alpha (catalytic), beta and
CC       gamma.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:7711835};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:7711835}. Cell
CC       membrane {ECO:0000269|PubMed:7711835}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:7711835}.
CC   -!- DISEASE: Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]: A
CC       subtype of migraine with aura associated with hemiparesis in some
CC       families. Migraine is a disabling symptom complex of periodic
CC       headaches, usually temporal and unilateral. Headaches are often
CC       accompanied by irritability, nausea, vomiting and photophobia,
CC       preceded by constriction of the cranial arteries. Migraine with
CC       aura is characterized by recurrent attacks of reversible
CC       neurological symptoms (aura) that precede or accompany the
CC       headache. Aura may include a combination of sensory disturbances,
CC       such as blurred vision, hallucinations, vertigo, numbness and
CC       difficulty in concentrating and speaking.
CC       {ECO:0000269|PubMed:12539047, ECO:0000269|PubMed:12953268,
CC       ECO:0000269|PubMed:21352219, ECO:0000269|PubMed:23838748,
CC       ECO:0000269|PubMed:23918834}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Alternating hemiplegia of childhood 1 (AHC1)
CC       [MIM:104290]: A rare syndrome of episodic hemi- or quadriplegia
CC       lasting minutes to days. Most cases are accompanied by dystonic
CC       posturing, choreoathetoid movements, nystagmus, other ocular motor
CC       abnormalities, autonomic disturbances, and progressive cognitive
CC       impairment. It is typically distinguished from familial hemiplegic
CC       migraine by infantile onset and high prevalence of associated
CC       neurological deficits that become increasingly obvious with age.
CC       {ECO:0000269|PubMed:15174025}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IIC subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34498.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05096; AAA51797.1; -; Genomic_DNA.
DR   EMBL; AB018321; BAA34498.2; ALT_INIT; mRNA.
DR   EMBL; AL121987; CAI15271.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52740.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52741.1; -; Genomic_DNA.
DR   EMBL; BC052271; AAH52271.2; -; mRNA.
DR   EMBL; M16795; AAA51799.1; -; mRNA.
DR   EMBL; M27578; AAA35575.1; -; Genomic_DNA.
DR   EMBL; M27571; AAA35575.1; JOINED; Genomic_DNA.
DR   EMBL; M27576; AAA35575.1; JOINED; Genomic_DNA.
DR   EMBL; Y07494; CAA68793.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS1196.1; -.
DR   PIR; A34474; A34474.
DR   RefSeq; NP_000693.1; NM_000702.3.
DR   UniGene; Hs.34114; -.
DR   ProteinModelPortal; P50993; -.
DR   SMR; P50993; -.
DR   BioGrid; 106967; 19.
DR   IntAct; P50993; 2.
DR   STRING; 9606.ENSP00000354490; -.
DR   ChEMBL; CHEMBL2095186; -.
DR   TCDB; 3.A.3.1.1; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; P50993; -.
DR   PhosphoSitePlus; P50993; -.
DR   SwissPalm; P50993; -.
DR   BioMuta; ATP1A2; -.
DR   DMDM; 1703467; -.
DR   EPD; P50993; -.
DR   MaxQB; P50993; -.
DR   PaxDb; P50993; -.
DR   PeptideAtlas; P50993; -.
DR   PRIDE; P50993; -.
DR   Ensembl; ENST00000361216; ENSP00000354490; ENSG00000018625.
DR   GeneID; 477; -.
DR   KEGG; hsa:477; -.
DR   UCSC; uc001fvc.4; human.
DR   CTD; 477; -.
DR   DisGeNET; 477; -.
DR   GeneCards; ATP1A2; -.
DR   GeneReviews; ATP1A2; -.
DR   HGNC; HGNC:800; ATP1A2.
DR   HPA; CAB022230; -.
DR   MalaCards; ATP1A2; -.
DR   MIM; 104290; phenotype.
DR   MIM; 182340; gene.
DR   MIM; 602481; phenotype.
DR   neXtProt; NX_P50993; -.
DR   OpenTargets; ENSG00000018625; -.
DR   Orphanet; 2131; Alternating hemiplegia of childhood.
DR   Orphanet; 569; Familial or sporadic hemiplegic migraine.
DR   PharmGKB; PA30796; -.
DR   eggNOG; KOG0203; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00850000132256; -.
DR   HOGENOM; HOG000265622; -.
DR   HOVERGEN; HBG004298; -.
DR   InParanoid; P50993; -.
DR   KO; K01539; -.
DR   OMA; MREAFNN; -.
DR   OrthoDB; EOG091G01BB; -.
DR   PhylomeDB; P50993; -.
DR   TreeFam; TF312838; -.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP1A2; human.
DR   GeneWiki; ATP1A2; -.
DR   GenomeRNAi; 477; -.
DR   PRO; PR:P50993; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000018625; -.
DR   CleanEx; HS_ATP1A2; -.
DR   ExpressionAtlas; P50993; baseline and differential.
DR   Genevisible; P50993; HS.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005391; F:sodium:potassium-exchanging ATPase activity; IDA:BHF-UCL.
DR   GO; GO:1990239; F:steroid hormone binding; IDA:BHF-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:Ensembl.
DR   GO; GO:0046034; P:ATP metabolic process; IMP:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; TAS:BHF-UCL.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IDA:BHF-UCL.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0040011; P:locomotion; IEA:Ensembl.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; TAS:BHF-UCL.
DR   GO; GO:0086009; P:membrane repolarization; TAS:BHF-UCL.
DR   GO; GO:1903170; P:negative regulation of calcium ion transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:1903280; P:negative regulation of calcium:sodium antiporter activity; ISS:BHF-UCL.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0045988; P:negative regulation of striated muscle contraction; IEA:Ensembl.
DR   GO; GO:0001504; P:neurotransmitter uptake; IEA:Ensembl.
DR   GO; GO:0010107; P:potassium ion import; IDA:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IC:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; NAS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:BHF-UCL.
DR   GO; GO:0051946; P:regulation of glutamate uptake involved in transmission of nerve impulse; NAS:BHF-UCL.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0006942; P:regulation of striated muscle contraction; NAS:UniProtKB.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; NAS:BHF-UCL.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL.
DR   GO; GO:1903416; P:response to glycoside; ISS:BHF-UCL.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0036376; P:sodium ion export from cell; IDA:BHF-UCL.
DR   GO; GO:0006814; P:sodium ion transport; NAS:UniProtKB.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 1.20.1110.10; -; 2.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 2.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01106; ATPase-IIC_X-K; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Disease mutation;
KW   Hydrolase; Ion transport; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Potassium; Potassium transport;
KW   Reference proteome; Sodium; Sodium transport;
KW   Sodium/potassium transport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P19156}.
FT   PROPEP        2      5       {ECO:0000250}.
FT                                /FTId=PRO_0000002503.
FT   CHAIN         6   1020       Sodium/potassium-transporting ATPase
FT                                subunit alpha-2.
FT                                /FTId=PRO_0000002504.
FT   TOPO_DOM      6     85       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     86    106       Helical. {ECO:0000255}.
FT   TOPO_DOM    107    129       Extracellular. {ECO:0000255}.
FT   TRANSMEM    130    150       Helical. {ECO:0000255}.
FT   TOPO_DOM    151    286       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    287    306       Helical. {ECO:0000255}.
FT   TOPO_DOM    307    318       Extracellular. {ECO:0000255}.
FT   TRANSMEM    319    336       Helical. {ECO:0000255}.
FT   TOPO_DOM    337    769       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    770    789       Helical. {ECO:0000255}.
FT   TOPO_DOM    790    799       Extracellular. {ECO:0000255}.
FT   TRANSMEM    800    820       Helical. {ECO:0000255}.
FT   TOPO_DOM    821    840       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    841    863       Helical. {ECO:0000255}.
FT   TOPO_DOM    864    915       Extracellular. {ECO:0000255}.
FT   TRANSMEM    916    935       Helical. {ECO:0000255}.
FT   TOPO_DOM    936    948       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    949    967       Helical. {ECO:0000255}.
FT   TOPO_DOM    968    982       Extracellular. {ECO:0000255}.
FT   TRANSMEM    983   1003       Helical. {ECO:0000255}.
FT   TOPO_DOM   1004   1020       Cytoplasmic. {ECO:0000255}.
FT   REGION       80     82       Interaction with phosphoinositide-3
FT                                kinase. {ECO:0000250}.
FT   ACT_SITE    374    374       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       714    714       Magnesium. {ECO:0000250}.
FT   METAL       718    718       Magnesium. {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIE5}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06687}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06686}.
FT   MOD_RES     450    450       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIE5}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06686}.
FT   MOD_RES     559    559       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIE5}.
FT   MOD_RES     570    570       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     587    587       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIE5}.
FT   MOD_RES     826    826       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09626}.
FT   MOD_RES     940    940       Phosphoserine; by PKA. {ECO:0000250}.
FT   VARIANT     366    366       G -> A (probable disease-associated
FT                                mutation found in a patient with early
FT                                infantile epileptic encephalopathy).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078231.
FT   VARIANT     378    378       T -> N (in AHC1; dbSNP:rs28934002).
FT                                {ECO:0000269|PubMed:15174025}.
FT                                /FTId=VAR_019934.
FT   VARIANT     593    593       R -> W (found in a patient with early
FT                                infantile epileptic encephalopathy;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078232.
FT   VARIANT     689    689       R -> Q (in FHM2; dbSNP:rs28933401).
FT                                {ECO:0000269|PubMed:12953268}.
FT                                /FTId=VAR_019935.
FT   VARIANT     715    715       G -> R (in FHM2; de novo mutation in a
FT                                sporadic case).
FT                                {ECO:0000269|PubMed:21352219}.
FT                                /FTId=VAR_065685.
FT   VARIANT     731    731       M -> T (in FHM2; dbSNP:rs28933400).
FT                                {ECO:0000269|PubMed:12953268}.
FT                                /FTId=VAR_019936.
FT   VARIANT     764    764       L -> P (in FHM2; loss of function;
FT                                dbSNP:rs28933398).
FT                                {ECO:0000269|PubMed:12539047}.
FT                                /FTId=VAR_019937.
FT   VARIANT     874    874       G -> S (in FHM2; some patients exhibit a
FT                                clinical overlap between migraine and
FT                                epilepsy). {ECO:0000269|PubMed:23918834}.
FT                                /FTId=VAR_069991.
FT   VARIANT     887    887       W -> R (in FHM2; loss of function;
FT                                dbSNP:rs28933399).
FT                                {ECO:0000269|PubMed:12539047}.
FT                                /FTId=VAR_019938.
FT   VARIANT    1007   1007       R -> W (in FHM2; some patients exhibit a
FT                                clinical overlap between migraine and
FT                                epilepsy). {ECO:0000269|PubMed:23838748}.
FT                                /FTId=VAR_069992.
SQ   SEQUENCE   1020 AA;  112265 MW;  AFBD8EA94FFB4FC3 CRC64;
     MGRGAGREYS PAATTAENGG GKKKQKEKEL DELKKEVAMD DHKLSLDELG RKYQVDLSKG
     LTNQRAQDVL ARDGPNALTP PPTTPEWVKF CRQLFGGFSI LLWIGAILCF LAYGIQAAME
     DEPSNDNLYL GVVLAAVVIV TGCFSYYQEA KSSKIMDSFK NMVPQQALVI REGEKMQINA
     EEVVVGDLVE VKGGDRVPAD LRIISSHGCK VDNSSLTGES EPQTRSPEFT HENPLETRNI
     CFFSTNCVEG TARGIVIATG DRTVMGRIAT LASGLEVGRT PIAMEIEHFI QLITGVAVFL
     GVSFFVLSLI LGYSWLEAVI FLIGIIVANV PEGLLATVTV CLTLTAKRMA RKNCLVKNLE
     AVETLGSTST ICSDKTGTLT QNRMTVAHMW FDNQIHEADT TEDQSGATFD KRSPTWTALS
     RIAGLCNRAV FKAGQENISV SKRDTAGDAS ESALLKCIEL SCGSVRKMRD RNPKVAEIPF
     NSTNKYQLSI HEREDSPQSH VLVMKGAPER ILDRCSTILV QGKEIPLDKE MQDAFQNAYM
     ELGGLGERVL GFCQLNLPSG KFPRGFKFDT DELNFPTEKL CFVGLMSMID PPRAAVPDAV
     GKCRSAGIKV IMVTGDHPIT AKAIAKGVGI ISEGNETVED IAARLNIPMS QVNPREAKAC
     VVHGSDLKDM TSEQLDEILK NHTEIVFART SPQQKLIIVE GCQRQGAIVA VTGDGVNDSP
     ALKKADIGIA MGISGSDVSK QAADMILLDD NFASIVTGVE EGRLIFDNLK KSIAYTLTSN
     IPEITPFLLF IIANIPLPLG TVTILCIDLG TDMVPAISLA YEAAESDIMK RQPRNSQTDK
     LVNERLISMA YGQIGMIQAL GGFFTYFVIL AENGFLPSRL LGIRLDWDDR TMNDLEDSYG
     QEWTYEQRKV VEFTCHTAFF ASIVVVQWAD LIICKTRRNS VFQQGMKNKI LIFGLLEETA
     LAAFLSYCPG MGVALRMYPL KVTWWFCAFP YSLLIFIYDE VRKLILRRYP GGWVEKETYY
//
